Aurinia Pharmaceuticals Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AUPH Nasdaq 2834 www.auriniapharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aurinia Pharmaceuticals Inc.

United rises on IPF results; Biogen scores positive lupus data and an approval - Mar 30th, 2026 9:00 am
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right - Mar 30th, 2026 6:00 am
Does Aurinia’s Tang‑Led Leadership Overhaul Reshape the Bull Case for Aurinia Pharmaceuticals (AUPH)? - Mar 29th, 2026 12:03 am
Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up - Mar 23rd, 2026 2:05 pm
MKT Capital Applauds Aurinia Pharmaceuticals’ Management Transition - Mar 23rd, 2026 9:00 am
Aurinia Announces Management Transition - Mar 23rd, 2026 6:00 am
Evommune Stock Sees RS Rating Rise To 91 - Mar 18th, 2026 11:11 am
Is Aurinia Pharmaceuticals (AUPH) Pricing Reflect Long Term Value After 71% One Year Gain - Mar 15th, 2026 4:08 pm
W.R. Berkley, Ziff Davis, and More Stocks See Action From Activist Investors - Mar 13th, 2026 7:30 pm
KalVista Pharmaceuticals Stock Sees RS Rating Jump To 86 - Mar 11th, 2026 12:36 pm
Viking Therapeutics Stock Gets RS Rating Upgrade - Mar 10th, 2026 12:29 pm
Xenon Pharmaceuticals Stock Sees RS Rating Rise To 77 - Mar 4th, 2026 11:35 am
Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors? - Mar 2nd, 2026 5:22 pm
Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Mar 1st, 2026 2:27 am
Aurinia Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Feb 26th, 2026 6:03 pm
Aurinia Pharmaceuticals Inc (AUPH) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... - Feb 26th, 2026 2:10 pm
Aurinia Pharmaceuticals Q4 Earnings Call Highlights - Feb 26th, 2026 10:06 am
Aurinia Results Highlight LUPKYNIS Momentum And New Aritinercept Growth Option - Feb 26th, 2026 7:11 am
Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates - Feb 26th, 2026 6:15 am
Aurinia: Q4 Earnings Snapshot - Feb 26th, 2026 4:12 am